Læknablaðið - 01.07.1978, Qupperneq 26

122
LÆKNABLAÐIÐ
HEIMILDIR
1. American Thoracic Society: Treatment of
Mycobacterial Disease, Amer. Rev. Resp.
Dis., 1977, 115, 185.
2. American Thoraeic Society’s Ad Hoc Com-
mittee on the Treatment of Tuberculosis
Patients in General Hospitals: Guidelines
for the general hospital in the admission
and care of tuberculosis patients, Amer.
Rev. Resp. Dis., 1969, 99, 631.
3. Aquinas, S.M., Allan, W.G.L., Horsfall, P.A.
L., Jenkins, P.K., Hung Yan, W., Girling, D.,
Tall, R., and Fox, W.: Adverse reactions to
daily and intermittent rifampicin regimens
for pulmonary tuberculosis in Hong Kong,
Brit. Med. J., 1972, 1, 765.
4. Bailey, W.C., Thomson, D.H., Jakobs, S.,
Ziskind, M., and Greenberg, H.B.: Evaluat-
ing the need for periodic recall and re-
examination of patients with inactive pul-
monary tuberculosis, Amer. Rev. Resp. Dis.,
1973, 107, 854.
5. Barlow, P.B.: Treatment of tuberculosis,
Basics of Respiratory Disease, Vol. 5, No. 1,
1976.
6. Bates, J.H., and Stead, W.W.: Effect of
chemotherapy on infectiousness of tubercu-
losis, New. Eng. J. Med. 1974, 290, 459.
7. Canetti, G.: Host factors and chemotherapy
of tuberculosis, Chemotherapy of Tubercu-
losis, 1964, 175.
8. Center for Disease Control: Recommenda-
tion for health department supervision of
tuberculosis patients, Morbid Mortal, 1974,
23, 75.
9. Corpe, R.F., and Blaloek, F.A.: A continuing
study of patients with „open negative“
status at Battey State Hospital, Amer. Rev.
Resp. Dis., 1968, 98, 954.
10. Doster, B., Murray, F.J., Newman, R. and
Woolpert, S.F.: Etambutol in the initial
treatment of pulmonary tuberculosis,
Amer. Rev. Resp. Dis., 1973, 107, 177.
11. Doyle, J.A., Lambertini, A., and Dolman,
A.: Intermittent chemotherapy with three
drugs in the treatment of pulmonary tuber-
culosis. Tubercle, 1970, 51, 397.
12. East African/British Medical Research
Council: Controlled clinic trial of four
shortcourse (6 months) regiments of ehemo-
therapy for treatment of pulmonary tuber-
culosis, Lancet, 1973, 1, 1332.
13. Eddison, G.G., and Farmer, B.M.: A con-
trolled study of home versus hospital treat-
ment of tuberculosis: 3 year study result,
Amer. Rev. Resp. Dis., 1971, 103, 886.
14. Edsall, J., and Collin, G.: Routine follow-up
of inactive tuberculosis, a practice to be
abandoned, Amer. Rev. Resp. Dis., 1973,
107, 851.
15. Eidus, L., Harnanasingh, A.M.T., Jessamine,
A.G.: Test for detection of ethambutol in
urine, Canad. J. Public Health, 1971, 62, 251.
16. Fox, W.: The John Barnwell lecture.
Changing concepts in the chemotherapy of
pulmonary tuberculosis, Amer. Rev. Resp.
Dis., 1968, 97, 767.
17. Fox, W.: Phillip Ellman lecture. Proceed-
ings of the Royal Society of Medicine, 1977,
70, 4.
18. Garibaldi, R.A., Drusin, R.E., Ferebee, S.H.
and Gregg, M.B.: Isoniazid associated hepa-
titis, Amer. Rev. Resp. Dis. 1972, 106, 357.
19. Groth-Petersen, B.: The significance of
chemotherapy for relapses from respiratory
tuberculosis, Scand. J. Resp. Dis., 1976, 57
108.
20. Grzybowski, S., McKinnon, Tuters, L.,
Pinkus, G. and Phillips, R.: Reactivations in
inactive pulmonary tuberculosis, Amer.
Rev. Resp. Dis., 1966, 93, 352.
21. Gunnels, J.J., Bates, J.H. and Swindoll, H.:
Infectiousness of cultur-positive tubercu-
losis patients on chemotherapy, Amer. Rev.
Resp. Dis., 1972, 105, 989.
22. Gunnels, J.J., Bates, J.H. and Swindoll, H.:
Infectivity of sputum positive tuberculosis
patients on chemotherapy, Amer. Rev.
Resp. Dis., 1974, 109, 323.
23. Hinshaw, H.C.: Management of Tubercu-
losis. Altered role of the primary care physi-
cian. Postgraduate Medicine, vol. 61, No. 4,
April 1977.
24. Johnston, R.F. and Wildrick, H.K.: „State
of the Art“ Review. The inpact of chemo-
therapy on the care of patients with tuber-
culosis, Amer. Rev. Resp. Dis., 1974, 109, 636.
25. Maddock, R.K., Jr.: Patient cooperation in
taking medicines, J.A.M.A., 1967, 199, 169.
26. MacDonald, J.B.: Mycobacterium tubercu-
losis resistance to rifampicin and etham-
buton, a clinical survey. Thorax, 1977, 32, 1.
27. Mitchison, D.A.: Chemotherapy of tubercu-
losis, a bacteriologist’s viewpoint. Brit. Med.
J„ 1965, 1, 1331.
23. National Institute of Health conference on
isoniazid liver injury: Clinical Spectrum
Pathology and Probable Pathogenesis, Ann.
Intern. Med. 84:181-192, 1976.
29. Ölafur E. Ólafsson, lyfjafræðingur, skrif-
legar upplýsingar.
30. Place, V.A., and Black, H. ed. New anti-
tuberculosis agents: Laboratory and clinical
studies, Ann. N.Y. Acad. Sci., 1966, 135, 681.
31. Reichman, L.B.: Routine follow-up of in-
active tuberculosis: A practice that has
been abandoned. Amer. Rev. Resp. Dis.,
1973, 180, 1442.
32. Reichman, L.B.: Tuberculosis care, when
and where? Ann. Intern. Med., 1974, 80:402.
33. Reichman, L.B., MacDondal, J.R.: Practical
management and control of tuberculosis.
The Med. Clin. of N.A., nov. 1977.
34. Rouillon, A., Perdrizet, 7., and Porrot, R.:
Transmission of tubercle bacilli: The effect
of chemotherapy, Tubercle, 1976, 57, 235.
35. Schiffman, P.L., Ashkar, B„ Bishop, M. and
Cleary, M.G.: Drug-Resistant tuberculosis
in a large southern California Hospital:
Amer. Rev. Resp. Dis„ 1977, 116, 821.